IO Biotech, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2020 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
IO Biotech, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q2 2025.
- IO Biotech, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was -$2.93M, a 340% decline year-over-year.
- IO Biotech, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was -$3.87M, a 163% decline year-over-year.
- IO Biotech, Inc. annual Nonoperating Income (Expense) for 2024 was $1.13M, a 81.8% decline from 2023.
- IO Biotech, Inc. annual Nonoperating Income (Expense) for 2023 was $6.21M, a 401% increase from 2022.
- IO Biotech, Inc. annual Nonoperating Income (Expense) for 2022 was $1.24M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)